Cargando…
What to Do with the New Antibiotics?
Multidrug-resistant Gram-negative bacteria-related infections have become a real public health problem and have exposed the risk of a therapeutic impasse. In recent years, many new antibiotics have been introduced to enrich the therapeutic armamentarium. Among these new molecules, some are mainly of...
Autores principales: | Chaïbi, Khalil, Jaureguy, Françoise, Do Rego, Hermann, Ruiz, Pablo, Mory, Céline, El Helali, Najoua, Mrabet, Sara, Mizrahi, Assaf, Zahar, Jean-Ralph, Pilmis, Benoît |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135159/ https://www.ncbi.nlm.nih.gov/pubmed/37107016 http://dx.doi.org/10.3390/antibiotics12040654 |
Ejemplares similares
-
Bloodstream Infections: Comparison of Diagnostic Methods and Therapeutic Consequences between a Hospital in a Resource-Limited Setting and Two French Hospitals
por: Eid, Racha, et al.
Publicado: (2023) -
Antimicrobial Stewardship Program: Reducing Antibiotic’s Spectrum of Activity Is not the Solution to Limit the Emergence of Multidrug-Resistant Bacteria
por: Saliba, Rindala, et al.
Publicado: (2022) -
Empiric Treatment in HAP/VAP: “Don’t You Want to Take a Leap of Faith?”
por: Chaïbi, Khalil, et al.
Publicado: (2022) -
Gut Microbiota, Antibiotic Therapy and Antimicrobial Resistance: A Narrative Review
por: Pilmis, Benoit, et al.
Publicado: (2020) -
When and How to Use MIC in Clinical Practice?
por: Magréault, Sophie, et al.
Publicado: (2022)